Related Experiment Video
Updated: Feb 12, 2026

Design of a Biocompatible Drug-Eluting Tracheal Stent in Mice with Laryngotracheal Stenosis
Published on: January 21, 2020
One-Year Clinical Outcomes of Forty-Eight Millimeter Everolimus-Eluting Stent Implanted in Very Long Lesions: A
Gioel Gabrio Secco1, Matteo Tebaldi, Rosario Parisi
1Interventional Cardiology, "Santi Antonio e Biagio e Cesare Arrigo" Hospital, Via Venezia 16, 15121 Alessandria, Italy. gioel.gabrio.secco@gmail.com.
Insights
A 48 mm everolimus-eluting stent (EES) provides a safe and effective treatment for long coronary lesions. This study found no significant difference in outcomes compared to overlapping drug-eluting stents.
Area of Science:
- Interventional Cardiology
- Cardiovascular Research
- Medical Device Technology
Background:
- Long coronary lesions present treatment challenges with higher restenosis rates.
- Overlapping stent struts may induce inflammatory reactions.
- Evaluating novel stent solutions for complex coronary anatomies is crucial.
Purpose of the Study:
- To assess the safety, feasibility, and cost-effectiveness of a 48 mm everolimus-eluting stent (EES).
- To treat patients with very long coronary lesions.
- To compare EES outcomes against conventional multi-stent strategies.
Main Methods:
- Prospective data collection of 218 patients treated with 48 mm EES.
- Propensity score matching to a control group of 218 patients receiving multiple second-generation drug-eluting stents.
- Primary endpoint: device-oriented composite endpoint (DOCE) including cardiac death, target-vessel myocardial infarction, and target-lesion revascularization.
Main Results:
- No significant difference in DOCE incidence between the 48 mm EES group (7%) and the control group (10.5%; P=.10).
- Overall, 9% of patients reached the primary endpoint.
- Myocardial infarction presentation and increased stent number were independent predictors of DOCE.
Conclusions:
- The 48 mm EES is a safe and effective option for treating very long coronary lesions.
- This approach simplifies treatment and potentially reduces complications associated with multiple overlapping stents.
Background:
Long coronary lesions still remain a challenge, with poor immediate results and suboptimal outcomes when compared to class A/B1 lesions. The presence of overlapped segments of metal struts and polymer might trigger an abnormal inflammatory reaction, resulting in a higher restenosis rate. The aim of our study was to evaluate the safety, feasibility, and cost effectiveness of a 48 mm everolimus-eluting stent (EES) during treatment of very long coronary lesions.
Methods And Results:
The FREIUS study is a prospective data collection of consecutive patients undergoing 48 mm EES implantation in six high-volume European centers. Each patient was matched through a propensity score to a comparable patient treated with two or more second-generation overlapped drug-eluting stents. The primary endpoint was the combined incidence of cardiac death, target-vessel myocardial infarction, and target-lesion revascularization (device-oriented composite endpoint [DOCE]). The secondary endpoints were all-cause death, each individual component of the primary endpoint, and definite/probable stent thrombosis. From January 2014 to April 2015, a total of 218 patients were treated with at least one 48 mm EES and were compared with 218 matched controls. Overall, 9% of patients reached the primary endpoint. Cumulative survival free from DOCE incidence did not differ between the two groups (7% in the cases vs 10.5% in the controls; P=.10). After multivariable analysis, only clinical presentation with myocardial infarction (hazard ratio [HR], 1.8; 95% confidence interval [CI], 1.5-2.1; P=.01) and stent number (HR, 1.4; 95% CI, 1.1-1.8; P=.02) emerged as independent predictors of DOCE.
Conclusion:
The use of 48 mm EES offers a safe and effective strategy for the treatment of very long coronary lesions.
Related Concept Videos
Sign Test for Matched Pairs
To conduct the sign test, we first calculate the differences in...
The Sense of Self: Reflected Self-Appraisal and Social Comparison
High-Performance Liquid Chromatography: Elution Process
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Predicting Reaction Outcomes
Outcomes of Glycolysis
Cellular respiration can occur aerobically (with oxygen) or anaerobically (without oxygen). In the presence of oxygen, cellular respiration starts with glycolysis and continues with pyruvate...

